Planta Med 2019; 85(05): 431-438
DOI: 10.1055/a-0828-8387
Natural Product Chemistry and Analytical Studies
Original Papers
Georg Thieme Verlag KG Stuttgart · New York

Analysis of Terpenes in Cannabis sativa L. Using GC/MS: Method Development, Validation, and Application

Elsayed A. Ibrahim
1   National Center for Natural Products Research, University of Mississippi, University, MS, USA
2   Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Suez Canal University, Ismailia, Egypt
,
Mei Wang
1   National Center for Natural Products Research, University of Mississippi, University, MS, USA
,
Mohamed M. Radwan
1   National Center for Natural Products Research, University of Mississippi, University, MS, USA
3   Pharmacognosy Department, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt
,
Amira S. Wanas
1   National Center for Natural Products Research, University of Mississippi, University, MS, USA
4   Pharmacognosy Department, Faculty of Pharmacy, Minia University, Minia, Egypt
,
Chandrani G. Majumdar
1   National Center for Natural Products Research, University of Mississippi, University, MS, USA
,
Baharthi Avula
1   National Center for Natural Products Research, University of Mississippi, University, MS, USA
,
Yan-Hong Wang
1   National Center for Natural Products Research, University of Mississippi, University, MS, USA
,
Ikhlas A. Khan
1   National Center for Natural Products Research, University of Mississippi, University, MS, USA
5   Department of Biomolecular Sciences, School of Pharmacy, University of Mississippi, University, MS, USA
,
Suman Chandra
1   National Center for Natural Products Research, University of Mississippi, University, MS, USA
,
Hemant Lata
1   National Center for Natural Products Research, University of Mississippi, University, MS, USA
,
Ghada M. Hadad
2   Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Suez Canal University, Ismailia, Egypt
,
Randa A. Abdel Salam
2   Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Suez Canal University, Ismailia, Egypt
,
Amany K. Ibrahim
6   Pharmacognosy Department, Faculty of Pharmacy, Suez Canal University, Ismailia, Egypt
,
Safwat A. Ahmed
6   Pharmacognosy Department, Faculty of Pharmacy, Suez Canal University, Ismailia, Egypt
,
Mahmoud A. ElSohly
1   National Center for Natural Products Research, University of Mississippi, University, MS, USA
7   Department of Pharmaceutics and Drug Delivery, School of Pharmacy, University of Mississippi, University, MS, USA
› Author Affiliations
Further Information

Publication History

received 15 May 2018
revised 04 December 2018

accepted 18 December 2018

Publication Date:
15 January 2019 (online)

Abstract

Terpenes are the major components of the essential oils present in various Cannabis sativa L. varieties. These compounds are responsible for the distinctive aromas and flavors. Besides the quantification of the cannabinoids, determination of the terpenes in C. sativa strains could be of importance for the plant selection process. At the University of Mississippi, a GC-MS method has been developed and validated for the quantification of terpenes in cannabis plant material, viz., α-pinene, β-pinene, β-myrcene, limonene, terpinolene, linalool, α-terpineol, β-caryophyllene, α-humulene, and caryophyllene oxide. The method was optimized and fully validated according to AOAC (Association of Official Analytical Chemists) guidelines against reference standards of selected terpenes. Samples were prepared by extraction of the plant material with ethyl acetate containing n-tridecane solution (100 µg/mL) as the internal standard. The concentration-response relationship for all analyzed terpenes using the developed method was linear with r2 values > 0.99. The average recoveries for all terpenes in spiked indoor cultivated samples were between 95.0 – 105.7%, with the exception of terpinolene (67 – 70%). The measured repeatability and intermediate precisions (% relative standard deviation) in all varieties ranged from 0.32 to 8.47%. The limit of detection and limit of quantitation for all targeted terpenes were determined to be 0.25 and 0.75 µg/mL, respectively. The proposed method is highly selective, reliable, and accurate and has been applied to the simultaneous determination of these major terpenes in the C. sativa biomass produced by our facility at the University of Mississippi as well as in confiscated marijuana samples.

Supporting Information

 
  • References

  • 1 Grotenhermen F. Pharmacology of cannabinoids. Neuro Endocrinol Lett 2004; 25: 14-23
  • 2 Whiting PF, Wolff RF, Deshpande S, Di Nisio M, Duffy S, Hernandez AV, Keurentjes JC, Lang S, Misso K, Ryder S. Cannabinoids for medical use: a systematic review and meta-analysis. JAMA 2015; 313: 2456-2473
  • 3 Andreae MH, Carter GM, Shaparin N, Suslov K, Ellis RJ, Ware MA, Abrams DI, Prasad H, Wilsey B, Indyk D. Inhaled cannabis for chronic neuropathic pain: a meta-analysis of individual patient data. J Pain 2015; 16: 1221-1232
  • 4 Blake DR, Robson P, Ho M, Jubb RW, McCabe CS. Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis. Rheumatology 2006; 45: 50-52
  • 5 Whittle BA, Guy GW, Robson P. Prospects for new cannabis-based prescription medicines. J Cannabis Ther 2001; 1: 183-205
  • 6 Guy GW, Stott CG. The Development of Sativex® – a natural cannabis-based Medicine. In: Mechoulam R. ed. Cannabinoids as Therapeutics. Basel: Birkhäuser Basel; 2005: 231-263
  • 7 Davis MP. Cannabinoids for symptom management and cancer therapy: the evidence. J Natl Compr Canc Netw 2016; 14: 915-922
  • 8 Gerich ME, Isfort RW, Brimhall B, Siegel CA. Medical marijuana for digestive disorders: high time to prescribe. Am J Gastroenterol 2015; 110: 208
  • 9 Amato L, Minozzi S, Mitrova Z, Parmelli E, Saulle R, Cruciani F, Vecchi S, Davoli M. Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy. Epidemiol Prev 2017; 41: 279-293
  • 10 Rudroff T, Honce JM. Cannabis and multiple sclerosis – The way forward. Front Neurol 2017; 8: 299
  • 11 Lee G, Grovey B, Furnish T, Wallace M. Medical cannabis for neuropathic pain. Curr Pain Headache Rep 2018; 22: 8
  • 12 Flores-Sanchez IJ, Verpoorte R. Secondary metabolism in cannabis. Phytochem Rev 2008; 7: 615-639
  • 13 Radwan MM, ElSohly MA, El-Alfy AT, Ahmed SA, Slade D, Husni AS, Manly SP, Wilson L, Seale S, Cutler SJ. Isolation and pharmacological evaluation of minor cannabinoids from high-potency Cannabis sativa . J Nat Prod 2015; 78: 1271-1276
  • 14 Ahmed SA, Ross SA, Slade D, Radwan MM, Khan IA, ElSohly MA. Minor oxygenated cannabinoids from high potency Cannabis sativa L. Phytochemistry 2015; 117: 194-199
  • 15 Pertwee R. ed. Handbook of Cannabis. New York: Oxford University Press; 2014
  • 16 Tzadok M, Uliel-Siboni S, Linder I, Kramer U, Epstein O, Menascu S, Nissenkorn A, Yosef OB, Hyman E, Granot D. CBD-enriched medical cannabis for intractable pediatric epilepsy: the current Israeli experience. Seizure 2016; 35: 41-44
  • 17 Cilio MR, Thiele EA, Devinsky O. The case for assessing cannabidiol in epilepsy. Epilepsia 2014; 55: 787-790
  • 18 Devinsky O, Cilio MR, Cross H, Fernandez-Ruiz J, French J, Hill C, Katz R, Di Marzo V, Jutras-Aswad D, Notcutt WG. Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia 2014; 55: 791-802
  • 19 Raphael B, Gabet Y. The skeletal endocannabinoid system: clinical and experimental insights. J Basic Clin Physiol Pharmacol 2016; 27: 237-245
  • 20 Hill KP. Medical marijuana for treatment of chronic pain and other medical and psychiatric problems: a clinical review. JAMA 2015; 313: 2474-2483
  • 21 Miyazawa M, Yamafuji C. Inhibition of acetylcholinesterase activity by bicyclic monoterpenoids. J Agric Food Chem 2005; 53: 1765-1768
  • 22 Nissen L, Zatta A, Stefanini I, Grandi S, Sgorbati B, Biavati B, Monti A. Characterization and antimicrobial activity of essential oils of industrial hemp varieties (Cannabis sativa L.). Fitoterapia 2010; 81: 413-419
  • 23 Gertsch J, Leonti M, Raduner S, Racz I, Chen JZ, Xie XQ, Altmann KH, Karsak M, Zimmer A. Beta-caryophyllene is a dietary cannabinoid. Proc Natl Acad Sci U S A 2008; 105: 9099-9104
  • 24 Klauke AL, Racz I, Pradier B, Markert A, Zimmer AM, Gertsch J, Zimmer A. The cannabinoid CB2 receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain. Eur Neuropsychopharmacol 2014; 24: 608-620
  • 25 Russo EB. Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol 2011; 163: 1344-1364
  • 26 Giese MW, Lewis MA, Giese L, Smith KM. Method for the analysis of cannabinoids and terpenes in cannabis. J AOAC Int 2015; 98: 1503-1522
  • 27 Casano S, Grassi G, Martini V, Michelozzi M. Variations in terpene profiles of different strains of Cannabis sativa L. Acta Hortic 2010; 925: 115-121
  • 28 Ferioli V, Rustichelli C, Pavesi G, Gamberini G. Analytical characterisation of hashish samples. Chromatographia 2000; 52: 39-44
  • 29 Careri M, Mangia A. Gas Chromatography-Mass Spectrometry Analysis of Flavors and Fragrances. In: Niessen WMA. ed. Current Practice Gas Chromatography-Mass Spectrometry. New York: CRC Press; 2001: 409
  • 30 Lockwood GB. Techniques for gas chromatography of volatile terpenoids from a range of matrices. J Chromatogr A 2001; 936: 23-31
  • 31 Omar J, Olivares M, Amigo JM, Etxebarria N. Resolution of co-eluting compounds of Cannabis sativa in comprehensive two-dimensional gas chromatography/mass spectrometry detection with multivariate curve resolution-alternating least squares. Talanta 2014; 121: 273-280
  • 32 Da Porto C, Decorti D, Natolino A. Separation of aroma compounds from industrial hemp inflorescences (Cannabis sativa L.) by supercritical CO2 extraction and on-line fractionation. Ind Crops Prod 2014; 58: 99-103
  • 33 Marchini M, Charvoz C, Dujourdy L, Baldovini N, Filippi JJ. Multidimensional analysis of cannabis volatile constituents: identification of 5, 5-dimethyl-1-vinylbicyclo[2.1.1]hexane as a volatile marker of hashish, the resin of Cannabis sativa L. J Chromatogr A 2014; 1370: 200-215
  • 34 Romano LL, Hazekamp A. Cannabis oil: chemical evaluation of an upcoming cannabis-based medicine. Cannabinoids 2013; 1: 1-11
  • 35 Sexton M, Shelton K, Haley P, West M. Evaluation of cannabinoid and terpenoid content: Cannabis flower compared to supercritical CO2 concentrate. Planta Med 2018; 84: 234-241
  • 36 Hazekamp A, Tejkalová K, Papadimitriou S. Cannabis: From cultivar to chemovar II – A metabolomics approach to cannabis classification. Cannabis Cannabinoid Res 2016; 1: 202-215
  • 37 Elzinga S, Fischedick J, Podkolinski R, Raber JC. Cannabinoids and terpenes as chemotaxonomic markers in cannabis. Nat Prod Chem Res 2015; 3: 2
  • 38 Howitz W. AOAC Guidelines for single laboratory Validation of chemical Methods for dietary Supplements and Botanicals. Gaithersburg MD USA: AOAC Int; 2002: 1219
  • 39 Ibrahim EA, Gul W, Gul SW, Stamper BJ, Hadad GM, Salam RAA, Ibrahim AK, Ahmed SA, Chandra S, Lata H. Determination of acid and neutral cannabinoids in extracts of different strains of Cannabis sativa using GC-FID. Planta Med 2018; 84: 250-259
  • 40 McPartland JM, Russo EB. Non-phytocannabinoid Constituents of Cannabis and herbal Synergy. In: Pertwee R. Handbook of Cannabis. New York: Oxford University Press; 2014: 280-295